1. Home
  2. Pharma & Healthcare
  3. Global Advanced Parenteral Drug Delivery Market By Product Type (Prefillable Syringes, Injectors Cartridges, Hypodermic Syringes, and IV Catheters Parenteral Delivery Devices), By Application (Central Nervous System Agents, Respiratory Agents, Hormones & Related Agents, Gastrointestinal Agents, Cardiovascular Agents, Anti-Infective Agents, Nutritional Agents, and Genito-Urinary Agents), By End-User (Government Hospitals, Private Hospitals and Clinics, and Healthcare Organizations) Global Advanced Parenteral Drug DeliveryIndustry Analysis, Size, Share, Growth, Trends, and Forecasts 2019-2025

Global Advanced Parenteral Drug Delivery Market By Product Type (Prefillable Syringes, Injectors Cartridges, Hypodermic Syringes, and IV Catheters Parenteral Delivery Devices), By Application (Central Nervous System Agents, Respiratory Agents, Hormones & Related Agents, Gastrointestinal Agents, Cardiovascular Agents, Anti-Infective Agents, Nutritional Agents, and Genito-Urinary Agents), By End-User (Government Hospitals, Private Hospitals and Clinics, and Healthcare Organizations) Global Advanced Parenteral Drug DeliveryIndustry Analysis, Size, Share, Growth, Trends, and Forecasts 2019-2025

Publication Month: Jun 2020 | No. of Pages: 120 Published By: Esticast Research & Consulting
Single User License: US $ 4700
Corporate User License: US $ 5600

Esticast Research and Consulting offers the latest published report on Global Advanced Parenteral Drug Delivery Market Analysis and Forecast from 2019 to 2026 delivering key insights and providing a competitive advantage to clients through a detailed report. Additionally, the report focuses on Advanced Parenteral Drug Delivery industry key players, to define and analyze the sales volume, value, market share, market competitive landscape, and recent developments.

Global Advanced Parenteral Drug Delivery market is estimated to reach $XX Million by 2025; growing at a CAGR of XX% till 2025.

About Global Advanced Parenteral Drug Delivery Market

Firstly, the report offers a basic overview of the industry including, definitions, classifications, applications, and industry chain scenario. The Advanced Parenteral Drug Delivery industry analysis is provided for the global market including development history, segment analysis, major regional developments, and a thorough competitor's evaluation.

Secondly, growth policies and plans are reviewed as well as manufacturing processes and cost structures. This report also discusses supply and consumption figures, import/export data, cost, price, revenue and gross margins by prime regions such as the U.S. Europe, China, and Japan along with other key regions. Moreover, Global Advanced Parenteral Drug Delivery Market proposes market trend analysis, drivers, and challenges by consumer behavior, and various marketing channels.

Competitive Glimpse

Top listed manufacturers for Global Global Advanced Parenteral Drug Delivery Market are:

Abbott Laboratories
Amgen
AptarGroup
AstraZeneca
Baxter
Becton
Boston Scientific
Bristol-Myers Squibb
Dickinson
GlaxoSmithKline
Hoffmann-La Roche
Novartis
Pfizer

With the slowdown in world economic growth, the Advanced Parenteral Drug Delivery industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years.

How has the competitive landscape of this industry been categorized?

The competitive scope of Global Advanced Parenteral Drug Delivery Market spans firms listed above, as per the report.
The report includes substantial information pertaining to the produced goods, company profile, revenue graph, as well as other production patterns.
The research study also presents details with respect to the market share that every company accounts for, as well as gross margins and price prototypes of the products.

Market Segmentation:

Esticast Research offers a crystal clear view of the various sections such as segmental analysis, regional analyst, product portfolios, followed by detailed information about market leaders and their strategies about mergers and acquisitions.

By Product Type

Prefillable Syringes
Injectors Cartridges
Hypodermic Syringes
IV Catheters Parenteral Delivery Devices
By Application

Central Nervous System Agents
Respiratory Agents
Hormones & Related Agents
Gastrointestinal Agents
Cardiovascular Agents
Anti-Infective Agents
Nutritional Agents
Genito-Urinary Agents
By End-User

Government Hospitals
Private Hospitals and Clinics
Healthcare Organizations

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

North America
Europe
Asia-Pacific
South America
The Middle East and Africa

Reasons to access this report:

Esticast Research and Consulting report is designed in a method that assists clients to gain a complete knowledge of the complete market scenario and the important sectors.
This report consists of meticulous overview of market dynamics, and thorough research.
Explore further market prospects and identify high potential categories based on comprehensive volume and value analysis
Detail information on competitive landscape, current market trends and evolving technologies that can be useful for the companies which are competing in this market
Gaining knowledge about competitive landscape based on thorough brand share analysis to plan an active market positioning

Table of Content

1. Market Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. Market Scope

2. Research Methodology
2.1. Primary Research
2.2. Research Methodology
2.3. Assumptions & Exclusions
2.4. Secondary data sources

3. Advanced Parenteral Drug Delivery Market Overview
3.1. Report Segmentation & Scope
3.2. Key Market Trend
3.3. Drivers
3.3.1. Direct access of the drug into the bloodstream and rapid onset of drug action at specific target sites
3.3.2. Increasing adoption of novel biological products and biosimilar
3.3.3. Increasing prevalence of chronic disorders such as diabetes, cardiovascular diseases and cancer
3.4. Restraints
3.4.1. Difficult to reverse its physiological effect
3.4.2. High cost associated with the manufacturing and packaging requirements of parental dosage form
3.5. Opportunity
3.5.1. Technological advancement in the area of parenteral drug delivery systems
3.5.2. Increasing demand for minimally invasive surgeries
3.6. Porter's Five Forces Analysis
3.6.1. Porter's Five Forces Analysis
3.7. Market Share Analysis

4. Product Type Overview
4.1. Introduction
4.1.1. Market Size & Forecast
4.2. Prefillable Syringes
4.2.1. Market Size & Forecast
4.3. Injectors Cartridges
4.3.1. Market Size & Forecast
4.4. Hypodermic Syringes
4.4.1. Market Size & Forecast
4.5. IV Catheters Parenteral Delivery Devices
4.5.1. Market Size & Forecast

5. Application Overview
5.1. Introduction
5.1.1. Market Size & Forecast
5.2. Central Nervous System Agents
5.2.1. Market Size & Forecast
5.3. Respiratory Agents
5.3.1. Market Size & Forecast
5.4. Hormones & Related Agents
5.4.1. Market Size & Forecast
5.5. Gastrointestinal Agents
5.5.1. Market Size & Forecast
5.6. Cardiovascular Agents
5.6.1. Market Size & Forecast
5.7. Anti-Infective Agents
5.7.1. Market Size & Forecast
5.8. Nutritional Agents
5.8.1. Market Size & Forecast
5.9. Genito-Urinary Agents
5.9.1. Market Size & Forecast

6. End-User Overview
6.1. Introduction
6.1.1. Market Size & Forecast
6.2. Government Hospitals
6.2.1. Market Size & Forecast
6.3. Private Hospitals and Clinics
6.3.1. Market Size & Forecast
6.4. Healthcare Organizations
6.4.1. Market Size & Forecast

7. Advanced Parenteral Drug Delivery Market Regional Overview
7.1. Introduction
7.1.1. Market Size & Forecast
7.2. North America Advanced Parenteral Drug Delivery Market
7.2.1. North America Market Size & Forecast, By Country
7.2.2. North America Market Size & Forecast, By Product Type
7.2.3. North America Market Size & Forecast, By Application
7.2.4. North America Market Size & Forecast, By End-User
7.2.5. The U.S.
7.2.5.1. Market Size and Forecast
7.2.6. Canada
7.2.6.1. Market Size and Forecast
7.2.7. Mexico
7.2.7.1. Market Size and Forecast
7.3. Europe Advanced Parenteral Drug Delivery Market
7.3.1. Europe Market Size & Forecast, By Country
7.3.2. Europe Market Size & Forecast, By Product Type
7.3.3. Europe Market Size & Forecast, By Application
7.3.4. Europe Market Size & Forecast, By End-User
7.3.5. Germany
7.3.5.1. Market Size and Forecast
7.3.6. France
7.3.6.1. Market Size and Forecast
7.3.7. UK
7.3.7.1. Market Size and Forecast
7.3.8. Italy
7.3.8.1. Market Size and Forecast
7.3.9. Spain
7.3.9.1. Market Size and Forecast
7.3.10. Rest of Europe
7.3.10.1. Market Size and Forecast
7.4. Asia-Pacific Advanced Parenteral Drug Delivery Market
7.4.1. Asia-Pacific Market Size & Forecast, By Country
7.4.2. Asia-Pacific Market Size & Forecast, By Product Type
7.4.3. Asia-Pacific Market Size & Forecast, By Application
7.4.4. Asia-Pacific Market Size & Forecast, By End-User
7.4.5. Japan
7.4.5.1. Market Size and Forecast
7.4.6. China
7.4.6.1. Market Size and Forecast
7.4.7. Australia
7.4.7.1. Market Size and Forecast
7.4.8. India
7.4.8.1. Market Size and Forecast
7.4.9. South Korea
7.4.9.1. Market Size and Forecast
7.4.10. Rest of Asia-Pacific
7.4.10.1. Market Size and Forecast
7.5. South America Advanced Parenteral Drug Delivery Market
7.5.1. South America Market Size & Forecast, By Country
7.5.2. South America Market Size & Forecast, By Product Type
7.5.3. South America Market Size & Forecast, By Application
7.5.4. South America Market Size & Forecast, By End-User
7.5.5. Brazil
7.5.5.1. Market Size and Forecast
7.5.6. Argentina
7.5.6.1. Market Size and Forecast
7.5.7. Rest of South America
7.5.7.1. Market Size and Forecast
7.6. Middle East & Africa Advanced Parenteral Drug Delivery Market
7.6.1. Middle East & Africa Market Size & Forecast, By Country
7.6.2. Middle East & Africa Market Size & Forecast, By Product Type
7.6.3. Middle East & Africa Market Size & Forecast, By Application
7.6.4. Middle East & Africa Market Size & Forecast, By End-User
7.6.5. GCC Countries
7.6.5.1. Market Size and Forecast
7.6.6. Egypt
7.6.6.1. Market Size and Forecast
7.6.7. South Africa
7.6.7.1. Market Size and Forecast
7.6.8. Rest of Middle East & Africa
7.6.8.1. Market Size and Forecast

8. Company Profile
8.1. Abbott Laboratories
8.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
8.1.2. Abbott Laboratories Product Category, Application, and Specification
8.1.3. Abbott Laboratories Financial Performance (2016-2018)
8.1.4. Main Business/Business Overview
8.2. Amgen
8.3. AptarGroup
8.4. AstraZeneca
8.5. Baxter
8.6. Becton
8.7. Boston Scientific
8.8. Bristol-Myers Squibb
8.9. Dickinson
8.10. GlaxoSmithKline
8.11. Hoffmann-La Roche
8.12. Novartis
8.13. Pfizer

Tables and Figures



Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets